Global Implantable Drug-Eluting Devices Market Research Report 2020

Publisher Name :
Date: 30-Oct-2020
No. of pages: 122
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Implantable Drug Infusion Pumps

- Intraocular Drug-Eluting Devices

- Contraceptive Drug-Eluting Devices

- Drug-Eluting Stents

- Others

Segment by Application

- Diabetes

- Contraception

- HIV/AIDS Prevention

- Chronic Pain Management

- Cardiovascular

- Ophthalmology

- Oncology

- Others

Global Implantable Drug-Eluting Devices Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Implantable Drug-Eluting Devices market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Implantable Drug-Eluting Devices Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

The major players in the market include Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, Allergan, Bausch & Lomb, REVA Medical, MicroPort Medical, etc.

Global Implantable Drug-Eluting Devices Market Research Report 2020

Table of Contents
1 Implantable Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Implantable Drug-Eluting Devices
1.2 Implantable Drug-Eluting Devices Segment by Type
1.2.1 Global Implantable Drug-Eluting Devices Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Implantable Drug-Eluting Devices Segment by Application
1.3.1 Implantable Drug-Eluting Devices Consumption Comparison by Application: 2020 VS 2026
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Global Implantable Drug-Eluting Devices Market by Region
1.4.1 Global Implantable Drug-Eluting Devices Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.5 Global Implantable Drug-Eluting Devices Growth Prospects
1.5.1 Global Implantable Drug-Eluting Devices Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Implantable Drug-Eluting Devices Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Implantable Drug-Eluting Devices Production Estimates and Forecasts (2015-2026)
1.6 Implantable Drug-Eluting Devices Industry
1.7 Implantable Drug-Eluting Devices Market Trends
2 Market Competition by Manufacturers
2.1 Global Implantable Drug-Eluting Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Implantable Drug-Eluting Devices Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Implantable Drug-Eluting Devices Production Sites, Area Served, Product Types
2.6 Implantable Drug-Eluting Devices Market Competitive Situation and Trends
2.6.1 Implantable Drug-Eluting Devices Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
3.1 Global Production Capacity of Implantable Drug-Eluting Devices Market Share by Regions (2015-2020)
3.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Regions (2015-2020)
3.3 Global Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Implantable Drug-Eluting Devices Production
3.4.1 North America Implantable Drug-Eluting Devices Production Growth Rate (2015-2020)
3.4.2 North America Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Implantable Drug-Eluting Devices Production
3.5.1 Europe Implantable Drug-Eluting Devices Production Growth Rate (2015-2020)
3.5.2 Europe Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Implantable Drug-Eluting Devices Production
3.6.1 China Implantable Drug-Eluting Devices Production Growth Rate (2015-2020)
3.6.2 China Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Implantable Drug-Eluting Devices Consumption by Regions
4.1 Global Implantable Drug-Eluting Devices Consumption by Regions
4.1.1 Global Implantable Drug-Eluting Devices Consumption by Region
4.1.2 Global Implantable Drug-Eluting Devices Consumption Market Share by Region
4.2 North America
4.2.1 North America Implantable Drug-Eluting Devices Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Implantable Drug-Eluting Devices Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Implantable Drug-Eluting Devices Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Implantable Drug-Eluting Devices Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Implantable Drug-Eluting Devices Production, Revenue, Price Trend by Type
5.1 Global Implantable Drug-Eluting Devices Production Market Share by Type (2015-2020)
5.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
5.3 Global Implantable Drug-Eluting Devices Price by Type (2015-2020)
5.4 Global Implantable Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Implantable Drug-Eluting Devices Market Analysis by Application
6.1 Global Implantable Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
6.2 Global Implantable Drug-Eluting Devices Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Implantable Drug-Eluting Devices Business
7.1 Pfizer
7.1.1 Pfizer Implantable Drug-Eluting Devices Production Sites and Area Served
7.1.2 Pfizer Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.1.3 Pfizer Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Pfizer Main Business and Markets Served
7.2 Medtronic
7.2.1 Medtronic Implantable Drug-Eluting Devices Production Sites and Area Served
7.2.2 Medtronic Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.2.3 Medtronic Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Medtronic Main Business and Markets Served
7.3 Merck
7.3.1 Merck Implantable Drug-Eluting Devices Production Sites and Area Served
7.3.2 Merck Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.3.3 Merck Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Merck Main Business and Markets Served
7.4 Bayer AG
7.4.1 Bayer AG Implantable Drug-Eluting Devices Production Sites and Area Served
7.4.2 Bayer AG Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.4.3 Bayer AG Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Bayer AG Main Business and Markets Served
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Implantable Drug-Eluting Devices Production Sites and Area Served
7.5.2 Johnson & Johnson Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Johnson & Johnson Main Business and Markets Served
7.6 Abbott
7.6.1 Abbott Implantable Drug-Eluting Devices Production Sites and Area Served
7.6.2 Abbott Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.6.3 Abbott Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Abbott Main Business and Markets Served
7.7 Surmodics
7.7.1 Surmodics Implantable Drug-Eluting Devices Production Sites and Area Served
7.7.2 Surmodics Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.7.3 Surmodics Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Surmodics Main Business and Markets Served
7.8 Boston Scientific Corporation
7.8.1 Boston Scientific Corporation Implantable Drug-Eluting Devices Production Sites and Area Served
7.8.2 Boston Scientific Corporation Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Boston Scientific Corporation Main Business and Markets Served
7.9 Titan Pharmaceuticals, Inc.
7.9.1 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Production Sites and Area Served
7.9.2 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Titan Pharmaceuticals, Inc. Main Business and Markets Served
7.10 BIOTRONIK
7.10.1 BIOTRONIK Implantable Drug-Eluting Devices Production Sites and Area Served
7.10.2 BIOTRONIK Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.10.3 BIOTRONIK Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 BIOTRONIK Main Business and Markets Served
7.11 Allergan
7.11.1 Allergan Implantable Drug-Eluting Devices Production Sites and Area Served
7.11.2 Allergan Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.11.3 Allergan Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Allergan Main Business and Markets Served
7.12 Bausch & Lomb
7.12.1 Bausch & Lomb Implantable Drug-Eluting Devices Production Sites and Area Served
7.12.2 Bausch & Lomb Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Bausch & Lomb Main Business and Markets Served
7.13 REVA Medical
7.13.1 REVA Medical Implantable Drug-Eluting Devices Production Sites and Area Served
7.13.2 REVA Medical Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.13.3 REVA Medical Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 REVA Medical Main Business and Markets Served
7.14 MicroPort Medical
7.14.1 MicroPort Medical Implantable Drug-Eluting Devices Production Sites and Area Served
7.14.2 MicroPort Medical Implantable Drug-Eluting Devices Product Introduction, Application and Specification
7.14.3 MicroPort Medical Implantable Drug-Eluting Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 MicroPort Medical Main Business and Markets Served
8 Implantable Drug-Eluting Devices Manufacturing Cost Analysis
8.1 Implantable Drug-Eluting Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
8.4 Implantable Drug-Eluting Devices Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Implantable Drug-Eluting Devices Distributors List
9.3 Implantable Drug-Eluting Devices Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Implantable Drug-Eluting Devices (2021-2026)
11.2 Global Forecasted Revenue of Implantable Drug-Eluting Devices (2021-2026)
11.3 Global Forecasted Price of Implantable Drug-Eluting Devices (2021-2026)
11.4 Global Implantable Drug-Eluting Devices Production Forecast by Regions (2021-2026)
11.4.1 North America Implantable Drug-Eluting Devices Production, Revenue Forecast (2021-2026)
11.4.2 Europe Implantable Drug-Eluting Devices Production, Revenue Forecast (2021-2026)
11.4.3 China Implantable Drug-Eluting Devices Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of Implantable Drug-Eluting Devices
12.2 North America Forecasted Consumption of Implantable Drug-Eluting Devices by Country
12.3 Europe Market Forecasted Consumption of Implantable Drug-Eluting Devices by Country
12.4 Asia Pacific Market Forecasted Consumption of Implantable Drug-Eluting Devices by Regions
12.5 Latin America Forecasted Consumption of Implantable Drug-Eluting Devices
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Implantable Drug-Eluting Devices by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Implantable Drug-Eluting Devices by Type (2021-2026)
13.1.2 Global Forecasted Price of Implantable Drug-Eluting Devices by Type (2021-2026)
13.2 Global Forecasted Consumption of Implantable Drug-Eluting Devices by Application (2021-2026)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Implantable Drug-Eluting Devices Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Implantable Drug-Eluting Devices Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Implantable Drug-Eluting Devices Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. Global Implantable Drug-Eluting Devices Production (K Units) by Manufacturers
Table 5. Global Implantable Drug-Eluting Devices Production (K Units) by Manufacturers (2015-2020)
Table 6. Global Implantable Drug-Eluting Devices Production Share by Manufacturers (2015-2020)
Table 7. Global Implantable Drug-Eluting Devices Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2019)
Table 10. Global Market Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Implantable Drug-Eluting Devices Production Sites and Area Served
Table 12. Manufacturers Implantable Drug-Eluting Devices Product Types
Table 13. Global Implantable Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Implantable Drug-Eluting Devices Capacity (K Units) by Region (2015-2020)
Table 16. Global Implantable Drug-Eluting Devices Production (K Units) by Region (2015-2020)
Table 17. Global Implantable Drug-Eluting Devices Revenue (Million US$) by Region (2015-2020)
Table 18. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
Table 19. Global Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 20. North America Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 21. Europe Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 22. China Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 23. Global Implantable Drug-Eluting Devices Consumption (K Units) Market by Region (2015-2020)
Table 24. Global Implantable Drug-Eluting Devices Consumption Market Share by Region (2015-2020)
Table 25. North America Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 26. Europe Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 27. Asia Pacific Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 28. Latin America Implantable Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)
Table 29. Global Implantable Drug-Eluting Devices Production (K Units) by Type (2015-2020)
Table 30. Global Implantable Drug-Eluting Devices Production Share by Type (2015-2020)
Table 31. Global Implantable Drug-Eluting Devices Revenue (Million US$) by Type (2015-2020)
Table 32. Global Implantable Drug-Eluting Devices Revenue Share by Type (2015-2020)
Table 33. Global Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2015-2020)
Table 34. Global Implantable Drug-Eluting Devices Consumption (K Units) by Application (2015-2020)
Table 35. Global Implantable Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
Table 36. Global Implantable Drug-Eluting Devices Consumption Growth Rate by Application (2015-2020)
Table 37. Pfizer Implantable Drug-Eluting Devices Production Sites and Area Served
Table 38. Pfizer Production Sites and Area Served
Table 39. Pfizer Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 40. Pfizer Main Business and Markets Served
Table 41. Medtronic Implantable Drug-Eluting Devices Production Sites and Area Served
Table 42. Medtronic Production Sites and Area Served
Table 43. Medtronic Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 44. Medtronic Main Business and Markets Served
Table 45. Merck Implantable Drug-Eluting Devices Production Sites and Area Served
Table 46. Merck Production Sites and Area Served
Table 47. Merck Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 48. Merck Main Business and Markets Served
Table 49. Bayer AG Implantable Drug-Eluting Devices Production Sites and Area Served
Table 50. Bayer AG Production Sites and Area Served
Table 51. Bayer AG Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 52. Bayer AG Main Business and Markets Served
Table 53. Johnson & Johnson Implantable Drug-Eluting Devices Production Sites and Area Served
Table 54. Johnson & Johnson Production Sites and Area Served
Table 55. Johnson & Johnson Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Johnson & Johnson Main Business and Markets Served
Table 57. Abbott Implantable Drug-Eluting Devices Production Sites and Area Served
Table 58. Abbott Production Sites and Area Served
Table 59. Abbott Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 60. Abbott Main Business and Markets Served
Table 61. Surmodics Implantable Drug-Eluting Devices Production Sites and Area Served
Table 62. Surmodics Production Sites and Area Served
Table 63. Surmodics Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Surmodics Main Business and Markets Served
Table 65. Boston Scientific Corporation Implantable Drug-Eluting Devices Production Sites and Area Served
Table 66. Boston Scientific Corporation Production Sites and Area Served
Table 67. Boston Scientific Corporation Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Boston Scientific Corporation Main Business and Markets Served
Table 69. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Production Sites and Area Served
Table 70. Titan Pharmaceuticals, Inc. Production Sites and Area Served
Table 71. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Titan Pharmaceuticals, Inc. Main Business and Markets Served
Table 73. BIOTRONIK Implantable Drug-Eluting Devices Production Sites and Area Served
Table 74. BIOTRONIK Production Sites and Area Served
Table 75. BIOTRONIK Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. BIOTRONIK Main Business and Markets Served
Table 77. Allergan Implantable Drug-Eluting Devices Production Sites and Area Served
Table 78. Allergan Production Sites and Area Served
Table 79. Allergan Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Allergan Main Business and Markets Served
Table 81. Bausch & Lomb Implantable Drug-Eluting Devices Production Sites and Area Served
Table 82. Bausch & Lomb Production Sites and Area Served
Table 83. Bausch & Lomb Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Bausch & Lomb Main Business and Markets Served
Table 85. REVA Medical Implantable Drug-Eluting Devices Production Sites and Area Served
Table 86. REVA Medical Production Sites and Area Served
Table 87. REVA Medical Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. REVA Medical Main Business and Markets Served
Table 89. MicroPort Medical Implantable Drug-Eluting Devices Production Sites and Area Served
Table 90. MicroPort Medical Production Sites and Area Served
Table 91. MicroPort Medical Implantable Drug-Eluting Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. MicroPort Medical Main Business and Markets Served
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Implantable Drug-Eluting Devices Distributors List
Table 96. Implantable Drug-Eluting Devices Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Implantable Drug-Eluting Devices Production (K Units) Forecast by Region (2021-2026)
Table 101. North America Implantable Drug-Eluting Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 102. Europe Implantable Drug-Eluting Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 103. Asia Pacific Implantable Drug-Eluting Devices Consumption Forecast 2021-2026 (K Units) by Regions
Table 104. Latin America Implantable Drug-Eluting Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 105. Global Implantable Drug-Eluting Devices Consumption (K Units) Forecast by Regions (2021-2026)
Table 106. Global Implantable Drug-Eluting Devices Production (K Units) Forecast by Type (2021-2026)
Table 107. Global Implantable Drug-Eluting Devices Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Implantable Drug-Eluting Devices Price (USD/Unit) Forecast by Type (2021-2026)
Table 109. Global Implantable Drug-Eluting Devices Consumption (K Units) Forecast by Application (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Implantable Drug-Eluting Devices
Figure 2. Global Implantable Drug-Eluting Devices Production Market Share by Type: 2020 VS 2026
Figure 3. Implantable Drug Infusion Pumps Product Picture
Figure 4. Intraocular Drug-Eluting Devices Product Picture
Figure 5. Contraceptive Drug-Eluting Devices Product Picture
Figure 6. Drug-Eluting Stents Product Picture
Figure 7. Others Product Picture
Figure 8. Global Implantable Drug-Eluting Devices Consumption Market Share by Application: 2020 VS 2026
Figure 9. Diabetes
Figure 10. Contraception
Figure 11. HIV/AIDS Prevention
Figure 12. Chronic Pain Management
Figure 13. Cardiovascular
Figure 14. Ophthalmology
Figure 15. Oncology
Figure 16. Others
Figure 17. North America Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 18. Europe Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 19. China Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 20. Global Implantable Drug-Eluting Devices Revenue (Million US$) (2015-2026)
Figure 21. Global Implantable Drug-Eluting Devices Production Capacity (K Units) (2015-2026)
Figure 22. Implantable Drug-Eluting Devices Production Share by Manufacturers in 2019
Figure 23. Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers in 2019
Figure 24. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Market Implantable Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers in 2019
Figure 26. The Global 5 and 10 Largest Players: Market Share by Implantable Drug-Eluting Devices Revenue in 2019
Figure 27. Global Implantable Drug-Eluting Devices Production Market Share by Region (2015-2020)
Figure 28. Global Implantable Drug-Eluting Devices Production Market Share by Region in 2019
Figure 29. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
Figure 30. Global Implantable Drug-Eluting Devices Revenue Market Share by Region in 2019
Figure 31. Global Implantable Drug-Eluting Devices Production (K Units) Growth Rate (2015-2020)
Figure 32. North America Implantable Drug-Eluting Devices Production (K Units) Growth Rate (2015-2020)
Figure 33. Europe Implantable Drug-Eluting Devices Production (K Units) Growth Rate (2015-2020)
Figure 34. China Implantable Drug-Eluting Devices Production (K Units) Growth Rate (2015-2020)
Figure 35. Global Implantable Drug-Eluting Devices Consumption Market Share by Region (2015-2020)
Figure 36. Global Implantable Drug-Eluting Devices Consumption Market Share by Region in 2019
Figure 37. North America Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 38. North America Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 39. Canada Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 41. Europe Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 42. Europe Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 43. Germany America Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 44. France Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 45. U.K. Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 46. Italy Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 47. Russia Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 48. Asia Pacific Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 49. Asia Pacific Implantable Drug-Eluting Devices Consumption Market Share by Regions in 2019
Figure 50. China Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 51. Japan Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 52. South Korea Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 54. Southeast Asia Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 55. India Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 56. Australia Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 58. Latin America Implantable Drug-Eluting Devices Consumption Market Share by Countries in 2019
Figure 59. Mexico Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 60. Brazil Implantable Drug-Eluting Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 61. Production Market Share of Implantable Drug-Eluting Devices by Type (2015-2020)
Figure 62. Production Market Share of Implantable Drug-Eluting Devices by Type in 2019
Figure 63. Revenue Share of Implantable Drug-Eluting Devices by Type (2015-2020)
Figure 64. Revenue Market Share of Implantable Drug-Eluting Devices by Type in 2019
Figure 65. Global Implantable Drug-Eluting Devices Production Growth by Type (2015-2020) (K Units)
Figure 66. Global Implantable Drug-Eluting Devices Consumption Market Share by Application (2015-2020)
Figure 67. Global Implantable Drug-Eluting Devices Consumption Market Share by Application in 2019
Figure 68. Global Implantable Drug-Eluting Devices Consumption Growth Rate by Application (2015-2020)
Figure 69. Price Trend of Key Raw Materials
Figure 70. Manufacturing Cost Structure of Implantable Drug-Eluting Devices
Figure 71. Manufacturing Process Analysis of Implantable Drug-Eluting Devices
Figure 72. Implantable Drug-Eluting Devices Industrial Chain Analysis
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 75. Porter's Five Forces Analysis
Figure 76. Global Implantable Drug-Eluting Devices Production Capacity (K Units) and Growth Rate Forecast (2021-2026)
Figure 77. Global Implantable Drug-Eluting Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 78. Global Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 79. Global Implantable Drug-Eluting Devices Price and Trend Forecast (2021-2026)
Figure 80. Global Implantable Drug-Eluting Devices Production Market Share Forecast by Region (2021-2026)
Figure 81. North America Implantable Drug-Eluting Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 82. North America Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 83. Europe Implantable Drug-Eluting Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 84. Europe Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 85. China Implantable Drug-Eluting Devices Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 86. China Implantable Drug-Eluting Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 87. Global Forecasted and Consumption Demand Analysis of Implantable Drug-Eluting Devices
Figure 88. North America Implantable Drug-Eluting Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 89. Europe Implantable Drug-Eluting Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 90. Asia Pacific Implantable Drug-Eluting Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 91. Latin America Implantable Drug-Eluting Devices Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 92. Global Implantable Drug-Eluting Devices Production (K Units) Forecast by Type (2021-2026)
Figure 93. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 94. Global Implantable Drug-Eluting Devices Consumption Forecast by Application (2021-2026)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
  • Global and Japan Ovarian Cancer Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 159
    Global Ovarian Cancer Diagnostics Scope and Market Size Ovarian Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the ......
  • Global and Japan Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 92
    Global Non-Invasive Cancer Diagnostics Scope and Market Size Non-Invasive Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segmen......
  • Global and China Diabetes Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 155
    Global Diabetes Therapeutics and Diagnostics Scope and Market Size Diabetes Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. ......
  • Global and United States Circulating Tumor Cell Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 127
    Global Circulating Tumor Cell Diagnostics Scope and Market Size Circulating Tumor Cell Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Mark......
  • Global and China Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 98
    Global Alzheimer's Disease Therapeutics and Diagnostics Scope and Market Size Alzheimer's Disease Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for......
  • Global and Japan Myocardial Infarction Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 99
    Global Myocardial Infarction Therapeutics Scope and Market Size Myocardial Infarction Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Myocardial Infarction Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Mark......
  • Global and China Angioedema Treatment Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 90
    Global Angioedema Treatment Scope and Market Size Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be spl......
  • Global and United States In Vivo Imaging Systems Market Insights, Forecast to 2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 134
    In Vivo Imaging Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global In Vivo Imaging Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the In Vivo Imaging Systems m......
  • Global and China Surface Plasmon Resonance (SPR) Market Size, Status and Forecast 2020-2026
    Published: 23-Nov-2020        Price: US 3900 Onwards        Pages: 98
    Global Surface Plasmon Resonance (SPR) Scope and Market Size Surface Plasmon Resonance (SPR) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Surface Plasmon Resonance (SPR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segmen......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs